In vivo delivery of RNAi with lipid-based nanoparticles.
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyThe Role of microRNAs in Stemness of Cancer Stem CellsCellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticlesTAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance.A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA.Maximizing the Supported Bilayer Phenomenon: Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery.Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity.Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer.Nanoparticle delivery of a peptide targeting EGFR signalingNanolipoparticles-mediated MDR1 siRNA delivery reduces doxorubicin resistance in breast cancer cells and silences MDR1 expression in xenograft model of human breast cancer.Combinatorial Approach to Nanoarchitectonics for Nonviral Delivery of Nucleic Acids.Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.Cystamine-terminated poly(beta-amino ester)s for siRNA delivery to human mesenchymal stem cells and enhancement of osteogenic differentiation.Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancerToward personalized cancer nanomedicine - past, present, and future.Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo.Gene therapy strategies in glaucoma and application for steroid-induced hypertensionThe delivery of therapeutic oligonucleotidesNanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis.Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy.Nanoparticles containing insoluble drug for cancer therapy.In vivo gene delivery by nonviral vectors: overcoming hurdles?Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules.Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.Plasmonic nanoprobes for intracellular sensing and imaging.Delivery of RNAi therapeutics: work in progress.Hepatic RNA Interference: Delivery by Synthetic Vectors.Recent advances in characterization of nonviral vectors for delivery of nucleic acids: impact on their biological performance.Lipid nanoparticles for gene delivery.Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer.Acid-degradable polymer-caged lipoplex (PCL) platform for siRNA delivery: facile cellular triggered release of siRNALiposome-targeted delivery for highly potent drugs.Lipid nanoparticles for hepatic delivery of small interfering RNA.The role of nanotechnology in the treatment of viral infections.Advances in Lipid Nanoparticles for siRNA Delivery.Hypoxia-targeted siRNA delivery.Engineering nanocages with polyglutamate domains for coupling to hydroxyapatite biomaterials and allograft bone.
P2860
Q26745710-031E8A1F-5B81-4AAB-AE83-B15B24DB80EBQ27005618-C173A408-4D2E-41A2-84AC-1CB9173DC126Q28538811-51BB954B-EC95-47E6-A145-6D73658C5F8EQ30438480-0A6F4E19-1FB9-42CB-B6FB-BB5C9BDC73B1Q33907576-9F948452-4297-4248-81BB-FEC1619CE6DAQ33908258-759EF9DA-D5ED-4DDA-901E-F2A52D7E8D6DQ34463222-D131F3A4-8E0A-4F6C-B9B2-184E4DBBDA4DQ34483455-E5375DA4-D266-4CAB-BE9B-6D35BD712286Q35589627-847FAAB2-1103-40C3-B936-0E9713B603F6Q35630481-81471915-B415-48D2-9A26-314DF4365243Q35853451-8D7F2F9D-CB9A-4C9C-ABB7-68064EC614E3Q36031889-FA41980A-3878-4777-973A-583FB40591D4Q36204816-29BBEBB0-B709-4C42-81A8-097B827835ACQ36356958-AE751466-2682-4279-AE58-3D38FE3659C5Q36472802-54C5F3C4-D9BD-487B-89F8-E7BB5260C628Q36968187-59E3319F-C0BD-4B9F-B8B8-51BD2D594CACQ37031613-28AE7680-0209-4BA2-898E-5E1013EE417AQ37060277-743AE417-AB7F-4CEE-AC9B-19D4263D5E8BQ37210936-046A6AF1-587A-48A1-85AE-0CABB84E88D1Q37229892-EDFF3F65-CB3B-4D50-8F32-B4CAB8B4F747Q37588032-FF90826C-73F0-4D55-A5A2-2F5E94C64423Q37636279-7DF7A8F4-F5C4-4234-B889-32D0F884A590Q37641455-1E7EC2F7-EBDC-4CEE-91B6-5A0C546045B4Q37693046-561A61B0-6592-4F65-B4A6-007606B50B64Q38004708-3F3F543B-8000-467B-97E9-3FCD07B06B15Q38011799-40966C2B-59C6-41DD-A611-D2C1A7694CC3Q38074442-F4D36FE5-2619-432A-9BCC-5367D805D429Q38105872-FCB3DD87-D733-4B67-92D9-3E97E87D6822Q38160246-6417CA10-85AB-4DAB-A2DC-85705A748B9BQ38200096-76FDCEBD-67E5-4CC1-A3A2-3672AA7C53E7Q38241667-AF86915C-646D-444D-AAF5-246638FDCFF8Q38269555-A602ED39-EB67-4687-AF82-176896041416Q38300047-36A25F6D-F814-4EBB-B1D7-8DF4DB4F1D5BQ39100867-7BFE7AF7-E9B0-4F4B-A1B2-944A571A8868Q39171223-E1F65807-9897-465A-BC28-037692432961Q39339170-0385395D-41AD-409D-9A84-ABA0E87AD7BFQ40106774-2419E0EC-82A8-4E8F-BAD7-C62D4E7C92FFQ41786279-71EF561F-05D3-4E32-B072-47FFEEF8DDD7Q41807205-7889A761-F969-4E56-AC6C-D6022FD5A808Q41875872-9E64E738-73CA-419F-A7C5-F9B8BD3712E1
P2860
In vivo delivery of RNAi with lipid-based nanoparticles.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo delivery of RNAi with lipid-based nanoparticles.
@en
In vivo delivery of RNAi with lipid-based nanoparticles.
@nl
type
label
In vivo delivery of RNAi with lipid-based nanoparticles.
@en
In vivo delivery of RNAi with lipid-based nanoparticles.
@nl
prefLabel
In vivo delivery of RNAi with lipid-based nanoparticles.
@en
In vivo delivery of RNAi with lipid-based nanoparticles.
@nl
P1476
In vivo delivery of RNAi with lipid-based nanoparticles.
@en
P2093
P304
P356
10.1146/ANNUREV-BIOENG-071910-124709
P407
P577
2011-08-01T00:00:00Z